vTv Therapeutics (NASDAQ:VTVT – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Saturday, Wall Street Zen reports. Other research analysts also recently issued reports about the company. Weiss Ratings downgraded vTv Therapeutics from a “sell (d+)” rating […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.